Last reviewed · How we verify
NIX Creme Rinse - 1% permethrin
At a glance
| Generic name | NIX Creme Rinse - 1% permethrin |
|---|---|
| Sponsor | ParaPRO LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation (PHASE4)
- Cocamide DEA vs Permethrin for Head Lice (PHASE3)
- Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin (NA)
- Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice (PHASE3)
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice (PHASE3)
- Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice (PHASE3)
- A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NIX Creme Rinse - 1% permethrin CI brief — competitive landscape report
- NIX Creme Rinse - 1% permethrin updates RSS · CI watch RSS
- ParaPRO LLC portfolio CI